We are live on ! Find out more
MDGSW

Medigus Ltd. Series C Warrant
MDGSW

Delisted

MDGSW was delisted on the 19th of July, 2023.

Back to rankings

4 hedge funds and large institutions have $10.2K invested in Medigus Ltd. Series C Warrant in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 2 → 4 (+2)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

45% less capital invested

Capital invested by funds: $18.6K → $10.2K (-$8.36K)

Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CH
CVI Holdings
Delaware
+$3.98K
2
AFM
Anson Funds Management
Texas
+$101

Top Sellers

1
UBS Group
UBS Group
Switzerland
-$6.49K
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
1
Anson Funds Management
Texas
$5.91K +$101 +1,400 New
AC
2
Armistice Capital
New York
$2.53K – +1 +0%
CH
3
CVI Holdings
Delaware
$1.64K +$3.98K +55,486 New
UBS Group
4
UBS Group
Switzerland
$148 -$6.49K -90,364 -95%

MDGSW Hedge Fund Activity: Q1 2023 in Review

4 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q1 2023, worth a combined $10.2K — down 45% from $18.6K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new MDGSW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was CVI Holdings, opening a new position worth an estimated $3.98K. The largest seller was UBS Group, cutting an estimated $6.49K.

  • 4 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q1 2023, up from 2 in Q4 2022.
  • Funds reported $10.2K of Medigus Ltd. Series C Warrant stock for Q1 2023, down 45% quarter-over-quarter.
  • 2 funds opened new Medigus Ltd. Series C Warrant positions in Q1 2023 and 0 closed out, a net change of +2 holders.
  • The largest Medigus Ltd. Series C Warrant buyer in Q1 2023 was CVI Holdings, an estimated $3.98K added.
  • The largest Medigus Ltd. Series C Warrant seller in Q1 2023 was UBS Group, an estimated $6.49K sold.

Based on aggregated 13F filings for Q1 2023.